Florham Park, NJ, United States of America

Peter William Heyman

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Peter William Heyman

Introduction

Peter William Heyman is an accomplished inventor based in Florham Park, NJ (US). He has made significant contributions to the field of drug delivery systems. His innovative approach has led to the development of a patented technology that enhances the efficiency of drug administration.

Latest Patents

Peter William Heyman holds a patent for a drug cartridge and drug delivery devices, along with methods for preparing them. The patent describes a method for creating a drug delivery device that features a body with at least one fluid duct. This duct is designed to convey medication from a reservoir to a needle for patient injection. A key aspect of the invention is the use of a barrier that is ultraviolet transmissive, which allows for the decontamination of the fluid duct through exposure to ultraviolet radiation.

Career Highlights

Peter is currently employed at Bristol-Myers Squibb Company, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in drug delivery systems has positioned him as a valuable asset to the company.

Collaborations

Peter has collaborated with Martin John McLoughlin, contributing to advancements in their field. Their partnership has fostered a creative environment that encourages innovation.

Conclusion

Peter William Heyman is a notable inventor whose work in drug delivery technology has the potential to improve patient care significantly. His contributions reflect a commitment to advancing medical technology through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…